Price $95.63 |
Market Cap
1.32B
|
Sector Health Care |
Div. Growth
115.80%
|
|
P/E
45.7
|
P/B
4.24
|
P/S
2.42
|
Dividend %
2.00%
|
|
P/CF
439.4
|
P/FCF
46.2
|
Op. Cash Flow
58.5K
|
FCF
2.2
|
|
Op. Margin
10.30%
|
Net Margin
5.30%
|
ROE
9.40%
|
ROI
8.90%
|
|
ROA
3.60%
|
EPS Growth
-6.70%
|
Current Ratio
1.3
|
Debt/Equity
55.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Chembio Diagnostics Inc (CEMI) | $0.44 | - | - | 16.4M | Strong Buy |
| Dare Bioscience Inc (DARE) | $1.06 | - | - | 95M | Strong Buy |
| Applied DNA Sciences Inc (APDN) | $1.15 | - | - | 17.7M | Strong Buy |
| DURECT Corp (DRRX) | $4.32 | - | - | 110.1M | Strong Buy |
| Dynatronics Corp (DYNT) | $1.49 | - | - | 7.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
